Repertoire Immune Medicines Interview Guide

Repertoire Immune Medicines is a pioneering biotechnology company committed to unlocking the full potential of the human immune system in the fight against cancer and autoimmune diseases. By focusing on the intricate dynamics of T cell receptor (TCR)-antigen immune synapses, Repertoire is positioned at the forefront of medical innovation. Utilizing its proprietary DECODE™ platform, the company meticulously characterizes TCR-antigen pairs, which plays a crucial role in the development of targeted immune therapies. With operations in both Cambridge, Massachusetts, and Zurich, Switzerland, Repertoire is actively advancing a diverse pipeline that features TCR bispecifics for multiple cancer types and mRNA tolerizing vaccines aimed at treating autoimmune disorders, all backed by strategic partnerships and a strong investor network.